Emapalumab

Tax included
Emapalumab (NI-0501) is a humanized monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH).
MedChemExpress 
HY-P99191

Data sheet

Size
Multiple sizes
Reactivity
IFNAR
Application
COVID-19-immunoregulation
CAS
1709815-23-5